These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16051943)

  • 1. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.
    Ellis LM; Curley SA; Grothey A
    J Clin Oncol; 2005 Aug; 23(22):4853-5. PubMed ID: 16051943
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
    Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
    Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
    Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
    Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
    Bilchik AJ; Hecht JR
    J Clin Oncol; 2008 Apr; 26(11):1786-8. PubMed ID: 18398144
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of perioperative bevacizumab use].
    Mariani P
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of the black sheep: is it bevacizumab or extended chemotherapy?
    Vauthey JN; Zorzi D
    Ann Surg Oncol; 2009 Jun; 16(6):1463-4. PubMed ID: 19357926
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
    Graziano F; Cascinu S
    J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
    Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.
    Kornprat P; Schöllnast H; Cerwenka H; Werkgartner G; Bernhardt G; Mischinger HJ
    Int J Colorectal Dis; 2009 Jan; 24(1):125-6. PubMed ID: 18682963
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.
    Klinger M; Eipeldauer S; Hacker S; Herberger B; Tamandl D; Dorfmeister M; Koelblinger C; Gruenberger B; Gruenberger T
    Eur J Surg Oncol; 2009 May; 35(5):515-20. PubMed ID: 19200687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases.
    Petrelli NJ
    J Clin Oncol; 2009 Apr; 27(11):1917; author reply 1918. PubMed ID: 19255304
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach.
    Lygidakis NJ; Bhagat AD; Vrachnos P; Grigorakos L
    Hepatogastroenterology; 2007 Jun; 54(76):1020-4. PubMed ID: 17629030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
    Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
    J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing cholangitis in the era of target chemotherapy: a possible anti-VEGF effect.
    Delis S; Triantopoulou C; Bakoyiannis A; Tassopoulos N; Athanasiou K; Dervenis C
    Dig Liver Dis; 2009 Jan; 41(1):72-7. PubMed ID: 18294938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
    Mahajan D; Miller C; Hirose K; McCullough A; Yerian L
    J Hepatol; 2008 Nov; 49(5):867-70. PubMed ID: 18814928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First- and second-line therapy of metastatic colorectal cancer.
    Terstriep S; Grothey A
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed bile leak with avastin after liver resection for metastatic colorectal cancer.
    Lordan JT; Wilkins M; Karanjia ND
    Hepatogastroenterology; 2011; 58(110-111):1769-70. PubMed ID: 22086700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of hepatic metastasis in colorectal cancer.
    Rossi H
    J Surg Oncol; 2005 Dec; 92(4):276-7. PubMed ID: 16299795
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
    Brostjan C; Gebhardt K; Gruenberger B; Steinrueck V; Zommer H; Freudenthaler H; Roka S; Gruenberger T
    Clin Cancer Res; 2008 Apr; 14(7):2065-74. PubMed ID: 18381946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
    D'Angelica M; Kornprat P; Gonen M; Chung KY; Jarnagin WR; DeMatteo RP; Fong Y; Kemeny N; Blumgart LH; Saltz LB
    Ann Surg Oncol; 2007 Feb; 14(2):759-65. PubMed ID: 17103075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.